Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, United States.
Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States.
Mult Scler Relat Disord. 2021 Aug;53:103037. doi: 10.1016/j.msard.2021.103037. Epub 2021 May 23.
To measure the longitudinal changes in three domains of financial hardship (i.e., financial worry, cost-related care non-adherence, material hardship) in patients with MS.
A convenience sample of 559 adult patients with a known diagnosis of MS visiting a single outpatient neurology clinic between July 2018 to February 2020 were approached. Patients completed surveys at baseline and 3, 6, 9, and 12 months post-enrollment. Outcomes included financial worry (using Comprehensive Score for Financial Toxicity Patient-Reported Outcome (COST)), cumulative cost-related care non-adherence, and cumulative financial hardship as adopted by Medical Expenditure Panel Survey (MEPS). Associations of financial worry with care non-adherence and material hardship were assessed using ANOVA.
A total of 242 (43.3%) participated at baseline. Mean age was 43.6 ± 13.6 years (76.9% female; 46.4% White); median months from diagnosis was 63 (IQR, 28-120). The mean COST score at enrollment was 17.43 (± 10.15) and increased to 19.41 (± 11.12) at 12 months (p = 0.09). Cumulative cost-related MS care non-adherence increased from 32.6% at baseline to 53.3% at 12 months (20.7% increase; p <0.001). Cumulative material hardship increased from 61.6% at baseline to 76.0% at 12 months (14.4% increase; p<0.001). Changes in COST score from baseline to 12 months were significantly associated with changes in non-adherence and material hardship (p<0.01).
Cost-related care non-adherence and material hardship accumulate progressively over time and correlates with financial worry. Clinical practices should focus on screening those at risk and intervene with the goal of mitigating costs of care and improving patient outcomes.
测量多发性硬化症患者在财务困难三个领域(即财务担忧、与成本相关的护理不遵医嘱、物质困难)的纵向变化。
从 2018 年 7 月至 2020 年 2 月期间,在一家单门诊神经科诊所就诊的 559 名已知多发性硬化症诊断的成年患者中,采用便利样本进行了研究。患者在基线和入组后 3、6、9 和 12 个月时完成了调查。结果包括财务担忧(使用综合财务毒性患者报告结果量表(COST))、累积与成本相关的护理不遵医嘱以及采用医疗支出面板调查(MEPS)的财务困难程度。使用方差分析评估财务担忧与护理不遵医嘱和物质困难之间的关联。
共有 242 人(43.3%)参加了基线调查。平均年龄为 43.6±13.6 岁(76.9%为女性;46.4%为白人);中位诊断后月数为 63(IQR,28-120)。入组时 COST 平均得分 17.43(±10.15),12 个月时增至 19.41(±11.12)(p=0.09)。与成本相关的多发性硬化症护理不遵医嘱的累积发生率从基线时的 32.6%增至 12 个月时的 53.3%(增加 20.7%;p<0.001)。物质困难的累积发生率从基线时的 61.6%增至 12 个月时的 76.0%(增加 14.4%;p<0.001)。从基线到 12 个月的 COST 评分变化与不遵医嘱和物质困难的变化显著相关(p<0.01)。
与成本相关的护理不遵医嘱和物质困难随时间逐渐累积,并与财务担忧相关。临床实践应侧重于对风险患者进行筛查,并采取干预措施,以减轻护理成本并改善患者结局。